Anti-PD-L1 biomimetic nanobubbles for ultrasound-triggered reprogramming of cold hepatocellular carcinoma for immunotherapy
{{output}}
Hepatocellular carcinoma exhibits profound resistance to immune checkpoint blockade due to its dense stromal architecture and immunosuppressive tumor microenvironment with an immune-excluded phenotype. To overcome this therapeutic challenge, we developed PD-1-... ...
